Want to see VTGN full AI Analyst Report?
VistaGen Therapeutics (VTGN) Ownership - Who Owns VistaGen Therapeutics?
VistaGen Therapeutics (VTGN) Ownership Overview
- 0.26% Insiders
- 4.28% Mutual Funds
- <0.01% Other Institutional Investors
- 3.55% ETFs
- 91.91% Public Companies and Individual Investors
The ownership structure of VistaGen Therapeutics (VTGN) stock is a mix of institutional, retail, and individual investors. Approximately 7.83% of the company’s stock is owned by Institutional Investors, 0.26% is owned by Insiders, and 91.91% is owned by Public Companies and Individual Investors.
The ownership structure of VistaGen Therapeutics (VTGN) stock is a mix of institutional, retail, and individual investors. Approximately 7.83% of the company’s stock is owned by Institutional Investors, 0.26% is owned by Insiders, and 91.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 1,574,200 | Institution | 3.55% | 264,466 |
| Vanguard Index Funds | 1,574,200 | Institution | 3.55% | 264,466 |
| Fidelity Concord Street Trust | 325,785 | Institution | 0.73% | 54,732 |
| Reid G. Adler | 60,868 | Insider | 0.14% | 10,226 |
| Shawn Singh | 38,903 | Insider | 0.09% | 6,536 |
| Joshua S. Prince | 15,249 | Insider | 0.03% | 2,562 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,574,200 | Institution | 3.55% | 264,466 |
| Fidelity Concord Street Trust | 325,785 | Institution | 0.73% | 54,732 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VTI ETF | 1,160,455 | Institution | 2.61% | 357,188 |
| Vanguard, VXF ETF | 413,745 | Institution | 0.93% | 127,351 |
FAQ
Who Owns VistaGen Therapeutics (VTGN)?
According to the latest TipRanks data, approximately 7.83% of the company's stock is held by institutional investors, 0.26% is held by insiders, and 91.91% is held by public companies and individual investors.
What percentage of VistaGen Therapeutics (VTGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.83% of VistaGen Therapeutics (VTGN) stock is held by institutional investors: 4.28% by mutual funds, 3.55% by ETFs and <0.01% by other institutional investors.
What percentage of VistaGen Therapeutics (VTGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 91.91% of VistaGen Therapeutics (VTGN) stock is held by public companies and individual investors.
Who owns the most shares of VistaGen Therapeutics (VTGN)?
Vanguard owns the most shares of VistaGen Therapeutics (VTGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.